Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Gordon syndrome (distal arthrogryposis type 3) is an autosomal dominant disorder characterized by congenital contractures of the limbs, cleft palate, and short stature. Heterozygous mutations in the mechanosensitive ion channel gene PIEZO2 are the primary cause of Gordon syndrome (MONDO:0007252).
Extensive genetic studies have identified 12 unrelated probands from 12 families with heterozygous PIEZO2 variants. Exome sequencing in five families, followed by Sanger validation in seven more, detected pathogenic variants in 10 of 12 individuals, including a recurrent missense hotspot c.8057G>A (p.Arg2686His) in nine families (PMID:24726473). A multigenerational pedigree with three affected members (father, son, neonate) segregated c.8057G>A across two additional relatives (PMID:27714920). A de novo truncating variant c.8576G>A (p.Trp2859Ter) was identified in a fetus presenting typical ultrasound features (PMID:37587573). This variant spectrum includes recurrent missense and truncating alleles, supporting autosomal dominant inheritance.
Segregation analysis in familial cases and the occurrence of de novo events provide strong genetic evidence. The predominant variant class is missense, with a recurrent p.Arg2686His, and other variants include nonsense alleles such as p.Trp2859Ter. The robust presence of PIEZO2 variants in unrelated families and de novo cases confirms its etiological role in Gordon syndrome.
Functional assays demonstrate that gain-of-function PIEZO2 mutations alter channel kinetics, increasing mechanically activated currents by faster recovery from inactivation and slowed inactivation, resulting in heightened channel activity (PMID:23487782). These electrophysiological findings align with the clinical phenotype of joint contractures seen in Gordon syndrome.
No studies to date dispute the association between PIEZO2 and Gordon syndrome. The cumulative genetic and functional data establish PIEZO2 as definitively associated with Gordon syndrome.
Key Take-home: Heterozygous PIEZO2 variants consistently cause autosomal dominant Gordon syndrome, supporting molecular diagnosis and informing genetic counseling.
Gene–Disease AssociationDefinitive12 unrelated probands (10 familial and 2 de novo) across 12 families; multigenerational segregation in one family (2 relatives); replicated over >8 y; functional concordance Genetic EvidenceStrong12 heterozygous variants in 12 probands; autosomal dominant inheritance; hotspot p.Arg2686His in nine families; de novo truncating variant Functional EvidenceModerateElectrophysiological studies of PIEZO2 gain-of-function mutations show increased channel activity consistent with contracture phenotype |